Related Experiment Video
Updated: Jul 7, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D
Min Du1, Robert L S Perry, Nathaniel B Nowacki
1Department of Biology, York University, 4700 Keele Street, Toronto M3J 1P3, Ontario, Canada.
Abstract:
Activation of protein kinase A (PKA) by elevation of the intracellular cyclic AMP (cAMP) level inhibits skeletal myogenesis. Previously, an indirect modulation of the myogenic regulatory factors (MRFs) was implicated as the mechanism. Because myocyte enhancer factor 2 (MEF2) proteins are key regulators of myogenesis and obligatory partners for the MRFs, here we assessed whether these proteins could be involved in PKA-mediated myogenic repression. Initially, in silico analysis revealed several consensus PKA phosphoacceptor sites on MEF2, and subsequent analysis by in vitro kinase assays indicated that PKA directly and efficiently phosphorylates MEF2D. Using mass spectrometric determination of phosphorylated residues, we document that MEF2D serine 121 and serine 190 are targeted by PKA. Transcriptional reporter gene assays to assess MEF2D function revealed that PKA potently represses the transactivation properties of MEF2D. Furthermore, engineered mutation of MEF2D PKA phosphoacceptor sites (serines 121 and 190 to alanine) rendered a PKA-resistant MEF2D protein, which efficiently rescues myogenesis from PKA-mediated repression. Concomitantly, increased intracellular cAMP-mediated PKA activation also resulted in an enhanced nuclear accumulation of histone deacetylase 4 (HDAC4) and a subsequent increase in the MEF2D-HDAC4 repressor complex. Collectively, these data identify MEF2D as a primary target of PKA signaling in myoblasts that leads to inhibition of the skeletal muscle differentiation program.
Insights
Protein kinase A (PKA) activation inhibits skeletal muscle development by directly phosphorylating myocyte enhancer factor 2D (MEF2D). This phosphorylation represses MEF2D activity, hindering muscle differentiation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Skeletal myogenesis is inhibited by protein kinase A (PKA) activation.
- Myogenic regulatory factors (MRFs) are indirectly modulated during PKA-mediated repression.
- Myocyte enhancer factor 2 (MEF2) proteins are crucial for myogenesis and partner with MRFs.
Purpose of the Study:
- To investigate the role of MEF2 proteins in PKA-mediated inhibition of skeletal myogenesis.
- To determine if PKA directly phosphorylates MEF2 proteins.
Main Methods:
- In silico analysis to identify PKA phosphoacceptor sites on MEF2.
- In vitro kinase assays to assess PKA phosphorylation of MEF2D.
- Mass spectrometry to identify specific phosphorylation sites on MEF2D.
- Transcriptional reporter gene assays to evaluate MEF2D function.
- Site-directed mutagenesis to create PKA-resistant MEF2D.
- Analysis of histone deacetylase 4 (HDAC4) nuclear accumulation.
Main Results:
- PKA directly and efficiently phosphorylates MEF2D at serine 121 and serine 190.
- PKA activation represses MEF2D's transactivation activity.
- Mutating MEF2D phosphorylation sites (S121A, S190A) confers resistance to PKA-mediated repression.
- PKA activation increases nuclear accumulation of HDAC4, enhancing the MEF2D-HDAC4 repressor complex.
Conclusions:
- MEF2D is a direct target of PKA signaling in myoblasts.
- PKA-mediated phosphorylation of MEF2D inhibits skeletal muscle differentiation.
- HDAC4 involvement in the MEF2D repressor complex is regulated by PKA signaling.
Related Concept Videos
Master Transcription Regulators
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation

